Alibaba Health - Public Comps and Valuation Multiples

Alibaba Health Overview

About Alibaba Health

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Founded

1998

HQ

Employees

1.4K+

Website

alihealth.cn

Sectors

Pharmacies
Vertical E-commerce
Consumer E-commerce
HealthTech

Financials

LTM Revenue $5.1B

LTM EBITDA $316M

EV

$11.1B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Alibaba Health Financials

As of September 2025, Alibaba Health reported last 12-month revenue of $5.1B and EBITDA of $316M.

In the same period, Alibaba Health generated $1.2B in LTM gross profit and $303M in net income.

See Alibaba Health valuation multiples based on analyst estimates

Alibaba Health P&L

In the most recent fiscal year, Alibaba Health reported revenue of $3.9B and EBITDA of $208M.

Alibaba Health expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Alibaba Health valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$5.1B	XXX	$3.9B	XXX	XXX	XXX
Gross Profit	$1.2B	XXX	$955M	XXX	XXX	XXX
Gross Margin	24%	XXX	24%	XXX	XXX	XXX
EBITDA	$316M	XXX	$208M	XXX	XXX	XXX
EBITDA Margin	6%	XXX	5%	XXX	XXX	XXX
EBIT	$313M	XXX	$203M	XXX	XXX	XXX
EBIT Margin	6%	XXX	5%	XXX	XXX	XXX
Net Profit	$303M	XXX	$184M	XXX	XXX	XXX
Net Margin	6%	XXX	5%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Alibaba Health including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $5.1B. EBITDA for the last twelve months was $316M. In the most recent fiscal year, Alibaba Health achieved $3.9B in revenue and $208M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$5.1B	Analyst estimates available to subscribers	$3.9B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$1.2B	Analyst estimates available to subscribers	$955M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	24.2% gross margin	Analyst estimates available to subscribers	24.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$316M	Analyst estimates available to subscribers	$208M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	6.2% EBITDA margin	Analyst estimates available to subscribers	5.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$313M	Analyst estimates available to subscribers	$203M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	6.2% EBIT margin	Analyst estimates available to subscribers	5.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$303M	Analyst estimates available to subscribers	$184M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	6.0% net profit margin	Analyst estimates available to subscribers	4.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Alibaba Health

This financial data table provides comprehensive performance metrics for Alibaba Health, a company based in Hong Kong. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Alibaba Health generated $5.1B in revenue over the last twelve months.
The company achieved $316M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $1.2B.
Net income over the last twelve months reached $303M.

Fiscal Year Performance

In the most recent fiscal year, Alibaba Health reported $3.9B in total revenue.
Fiscal year EBITDA was $208M.
The company maintained a gross profit margin of 24.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was 5.3%.
Net profit margin reached 4.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Alibaba Health. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Alibaba Health Stock Performance

Alibaba Health has current market cap of HKD 95.3B (or $12.2B), and EV of HKD 86.5B (or $11.1B).

Market Cap Evolution

Alibaba Health Stock Data

As of October 17, 2025, Alibaba Health's stock price is HKD 6 (or $1).

See Alibaba Health trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$11.1B	$12.2B	XXX	XXX	XXX	XXX	$0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Alibaba Health Valuation Multiples

Alibaba Health's trades at 2.9x EV/Revenue multiple, and 59.0x EV/EBITDA.

See valuation multiples for Alibaba Health and 15K+ public comps

Alibaba Health Financial Valuation Multiples

As of October 17, 2025, Alibaba Health has market cap of $12.2B and EV of $11.1B.

Equity research analysts estimate Alibaba Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Alibaba Health has a P/E ratio of 44.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$12.2B	XXX	$12.2B	XXX	XXX	XXX
EV (current)	$11.1B	XXX	$11.1B	XXX	XXX	XXX
EV/Revenue	2.4x	XXX	2.9x	XXX	XXX	XXX
EV/EBITDA	38.4x	XXX	59.0x	XXX	XXX	XXX
EV/EBIT	38.7x	XXX	63.5x	XXX	XXX	XXX
EV/Gross Profit	9.9x	XXX	n/a	XXX	XXX	XXX
P/E	44.1x	XXX	73.6x	XXX	XXX	XXX
EV/FCF	37.5x	XXX	66.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Alibaba Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Alibaba Health Margins & Growth Rates

Alibaba Health's last 12 month revenue growth is 15%

Alibaba Health's revenue per employee in the last FY averaged $2.9M, while opex per employee averaged $0.6M for the same period.

Alibaba Health's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alibaba Health's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Alibaba Health and other 15K+ public comps

Alibaba Health Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	15%	XXX	19%	XXX	XXX	XXX
EBITDA Margin	6%	XXX	5%	XXX	XXX	XXX
EBITDA Growth	40%	XXX	51%	XXX	XXX	XXX
Rule of 40	19%	XXX	19%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	43%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$2.9M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.6M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	7%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	19%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial